Historic: Federal Agency Awards Grant For Psychedelics Research, First Time In 50 years

The National Institutes of Health awarded a nearly $4 million grant meant to fund research on psilocybin, the active ingredient in “magic mushrooms,” to researchers at Johns Hopkins University.

The event marks the first grant awarded by the federal agency to any research relating to a classic psychedelic molecule in over half a century, according to an independent study.

The funds will be used to study the therapeutic use of psilocybin therapy in nicotine addiction and smoking cessation, in collaboration with Mydecine Innovations Group MYCOF.

The Phase 2/3 study will be conducted during three years in collaboration with the University of Alabama at Birmingham and New York University, according to a NewsWise report.

“The historical importance of this grant is monumental,” said principal investigator Matthew Johnson, Ph.D., Professor in Psychedelics and Consciousness in the Department of Psychiatry and Behavioral Sciences at Johns Hopkins.

“We knew it was only a matter of time before the NIH would fund this work because the data are so compelling and because this work has demonstrated to be safe. Psilocybin does have very real risks, but these risks are squarely mitigated in controlled settings through screening, preparation, monitoring and follow-up care,” Johnson added.

Benzinga Photo.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisPenny StocksMarketsJohns HopkinsMatthew JohnsonNational Institutes of Health
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.